Chen Peizhe, an academician of the Taiwan Institute of Technology, who had withdrawn from the Self -producing vaccine review committee for high -end disputes, believes that the officially announced high -end vaccine contract content is beneficial to the Taiwan Centers for Disease Control.New Legislative Yuan surveyed high -end disputes.
The vaccination was slow during the crown disease epidemic, and the government supported high -end companies to develop vaccines by themselves, causing many questions including stock trading.
According to the Taiwan United Daily News and the Free Times, high -end coronary vaccines have triggered Taiwan's social concerns from contract content, contract conditions to the emergency authorization process.The Department of Health and Welfare's Disease Control Department on Tuesday (January 16) announced the contract content after obtaining the consent of the high -end board.
The two parties originally agreed that the contract confidentiality period was five years after the contract was signed.The Department of Diseases said that for Zhao Gongxin, both sides agreed to make public publicity in advance.
Chen Peizhe believes that the government's willingness to publish contracts is a small step towards transparentness, but there is no way to solve problems and resolve social doubts, nor does it know how much the government's contract content is.
Chen Peizhe said that there are many places that the outside world does not understand about the discussions related to vaccine procurement, including funding and policy formulation.As a stakeholder, the content of the contract is definitely beneficial to themselves. To allow the sunlight to enter the government's vaccine policy, the results need to be announced by a third -party investigation of public credibility to solve the doubts of the people.
He emphasized that Taiwanese society should have the right to know (the right to know).The process is public.
